Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agenus

2.91
-0.1300-4.28%
Post-market: 2.950.0400+1.37%19:06 EDT
Volume:783.29K
Turnover:2.31M
Market Cap:79.07M
PE:-0.27
High:3.12
Open:3.04
Low:2.83
Close:3.04
Loading ...

Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications

Business Wire
·
27 Feb

Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference

Business Wire
·
26 Feb

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

THOMSON REUTERS
·
25 Feb

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

Business Wire
·
25 Feb

Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting

Business Wire
·
24 Feb

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Zacks
·
21 Feb

Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting

Business Wire
·
13 Feb

Incyte terminates license agreement with Agenus

TIPRANKS
·
11 Feb

BRIEF-Agenus Inc - Incyte To Terminate Agreement With Agenus Effective February 2026

Reuters
·
11 Feb

Agenus Inc - Rights to Lag-3 and Tim-3 Revert to Agenus

THOMSON REUTERS
·
11 Feb

Agenus Regains Rights to LAG-3 and TIM-3 Programs

TIPRANKS
·
11 Feb

Agenus (AGEN) Is Attractively Priced Despite Fast-paced Momentum

Zacks
·
06 Feb

Are Medical Stocks Lagging Agenus (AGEN) This Year?

Zacks
·
05 Feb

Agenus reports publication of data from bot/bal combination in JOCO

TIPRANKS
·
30 Jan

Agenus Announces Publication in the Journal of Clinical Oncology Highlighting Data from Botensilimab Plus Balstilimab in Relapsed/Refractory Metastatic Sarcomas

Business Wire
·
30 Jan

H.C. Wainwright Sticks to Their Hold Rating for Agenus (AGEN)

TIPRANKS
·
28 Jan

Agenus presents updated bot/bal data at ASCO-GI, says H.C. Wainwright

TIPRANKS
·
28 Jan

Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease

Business Wire
·
23 Jan

What Makes Agenus (AGEN) a New Buy Stock

Zacks
·
21 Jan

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Zacks
·
20 Jan